Cognitive symptoms after COVID-19 DOI Creative Commons
Miren Altuna,

Ma Belén Sánchez‐Saudinós,

Alberto Lleó

и другие.

Neurology Perspectives, Год журнала: 2021, Номер 1, С. S16 - S24

Опубликована: Дек. 1, 2021

SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond acute phase of infection.

Язык: Английский

Neurocognitive Impairment in Long COVID: A Systematic Review DOI Creative Commons

Ευγενία Παναγέα,

Lambros Messinis,

Maria Christina Petri

и другие.

Archives of Clinical Neuropsychology, Год журнала: 2024, Номер unknown

Опубликована: Июнь 8, 2024

Abstract Objective Although Coronavirus disease 2019 (COVID-19) is primarily a respiratory infectious disease, it has also been associated with wide range of other clinical manifestations. It widely accepted in the scientific community that many patients after recovery continue to experience COVID-19-related symptoms, including cognitive impairment. The aim this systematic review was investigate profile long-COVID syndrome. Methods A search empirical studies conducted through PubMed/Medline and Scopus electronic databases. Cross-sectional longitudinal published between 2020 2023 were included. Results Of 516 assessed for eligibility, 36 met inclusion criteria. All included support presence persistent changes COVID-19 disease. Executive function, memory, attention, processing speed appear be domains are predominantly syndrome, whereas language an area not sufficiently investigated. Conclusions In review, high frequency impairment evident. If we consider functioning affects our ability live independently key determinant quality life, imperative precisely define those factors may induce survivors, ultimate goal early diagnosis and, consequently, development targeted rehabilitation interventions address them.

Язык: Английский

Процитировано

11

Changes in memory and cognition during the SARS-CoV-2 human challenge study DOI Creative Commons
William Trender, Peter J. Hellyer, Ben Killingley

и другие.

EClinicalMedicine, Год журнала: 2024, Номер 76, С. 102842 - 102842

Опубликована: Сен. 21, 2024

Язык: Английский

Процитировано

11

Electroencephalographic Biomarkers for Neuropsychiatric Diseases: The State of the Art DOI Creative Commons
Nayeli Huidobro,

Roberto Meza-Andrade,

Ignacio Méndez‐Balbuena

и другие.

Bioengineering, Год журнала: 2025, Номер 12(3), С. 295 - 295

Опубликована: Март 14, 2025

Because of their nature, biomarkers for neuropsychiatric diseases were out the reach medical diagnostic technology until past few decades. In recent years, confluence greater, affordable computer power with need more efficient diagnoses and treatments has increased interest in possibility discovery. This review will focus on progress made over ten years regarding search electroencephalographic diseases. includes algorithms methods analysis, machine learning, quantitative electroencephalography as applied to neurodegenerative neurodevelopmental well traumatic brain injury COVID-19. Our findings suggest that there is a consensus among researchers classification most suit this field; slight disconnection between development increasingly sophisticated analysis what they actually be use clinical setting; finally, are favored type field caveats. The main goal state-of-the-art provide reader general panorama state art field.

Язык: Английский

Процитировано

1

COVID-19 Pandemic–Related Exposures and Cognitive Function in Middle-Aged Women DOI Creative Commons
Siwen Wang,

Anthony Menor,

Lori B. Chibnik

и другие.

JAMA Network Open, Год журнала: 2025, Номер 8(4), С. e255532 - e255532

Опубликована: Апрель 17, 2025

Importance The COVID-19 pandemic has been associated with risk factors for cognitive decline, such as bereavement and SARS-CoV-2 infection. Objective To examine whether the pandemic-related exposures are function among middle-aged women. Design, Setting, Participants This cohort study analyzed data from Nurses’ Health Study II, an ongoing of registered nurses in US. present focused on women aged 51 to 76 years who completed 2 8 objective assessments both prior (October 1, 2014, February 29, 2020) during (March 2020, September 30, 2022). Statistical analyses were performed January 2023 2025. Exposure pandemic. Main Outcomes Measures Two standardized (ie, z -scored) composite scores (psychomotor speed attention, learning working memory) a global score constituted primary outcomes. Higher indicated better function. Cognitive was assessed using Cogstate Brief Battery, computer-administered test battery. every 6 12 months. Results A total 5191 (mean [SD] age at first assessment, 63.0 [4.8] years) prepandemic during-pandemic measures, contributing 23 678 assessments. After adjustment educational level participants their parents, practice effects, comorbidities (eg, diabetes, hypertension), no difference observed between taken vs before attention: β = −0.01 SD [95% CI, −0.05 0.02 SD]; memory: 0.00 −0.03 0.03 score: SD]). Among 4456 responded substudy surveys about events), those history infection (164 [3.7%]) or post–COVID-19 conditions (PCC; 62 [1.4%]), median (IQR) 20.0 (18.5-22.1) months after initial infection, had reduced compared without PCC; however, these differences did not reach statistical significance, wide CIs suggested considerable uncertainty. Conclusions Relevance found that events decline up 2.5 onset Future studies needed long-term implications PCC

Язык: Английский

Процитировано

1

Cognitive symptoms after COVID-19 DOI Creative Commons
Miren Altuna,

Ma Belén Sánchez‐Saudinós,

Alberto Lleó

и другие.

Neurology Perspectives, Год журнала: 2021, Номер 1, С. S16 - S24

Опубликована: Дек. 1, 2021

SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond acute phase of infection.

Язык: Английский

Процитировано

48